Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
SNGX = MC $55 M /Covid 19 Vaccine / 3x Phase 3 Drugs with data in Q4 /low float =The CHEAPEST of all Covid Vaccine Gems and most attractive because of their full product pipeline and extremely low valuation ..could be the next NVAX .........GLTA
http://news.santafenewsonline.com/story/205021/soligenix-inc-set-to-leverage-its-milestone-filled-2019-toward-a-transformational-2020-chief-scientific-officer-featured-in-pharmavoice-podcast.html
SNGX = MC $55 M /Covid 19 Vaccine / 3x Phase 3 Drugs with data in Q4 /low float =The CHEAPEST of all Covid Vaccine Gems and most attractive because of their full product pipeline and extremely low valuation ..could be the next NVAX .........GLTA
http://news.santafenewsonline.com/story/205021/soligenix-inc-set-to-leverage-its-milestone-filled-2019-toward-a-transformational-2020-chief-scientific-officer-featured-in-pharmavoice-podcast.html
SNGX = MC $55 M /Covid 19 Vaccine / 3x Phase 3 Drugs with data in Q4 /low float =The CHEAPEST of all Covid Vaccine Gems and most attractive because of their full product pipeline
http://news.santafenewsonline.com/story/205021/soligenix-inc-set-to-leverage-its-milestone-filled-2019-toward-a-transformational-2020-chief-scientific-officer-featured-in-pharmavoice-podcast.html
Major breakout toward 10 dollar coming
RALLLYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYY next potential 10+ BAgger
ChEAPEST Covid 19 Vaccine gem could be the hottest Pick for the coming days and weeks ..Market cap of 55 million is a PURE GIFT for a company which has also 3 Products in Phase 3...STRONG BUY AGGRESSIVE
Soligenix Inc. Set To Leverage Its Milestone Filled 2019 Toward A Transformational 2020; Chief Scientific Officer Featured In PharmaVOICE Podcast
http://news.santafenewsonline.com/story/205021/soligenix-inc-set-to-leverage-its-milestone-filled-2019-toward-a-transformational-2020-chief-scientific-officer-featured-in-pharmavoice-podcast.html
Soligenix Presentation at 2020 MedInvest Infectious Disease & Immunology Conference
SNGX =CHEAPEST Covid 19 Vaccine gem with alaughable marketcap of less than 60 million and they have also 3 Phase 3 Assets with data coming in Q4 ..maybe the next INO or NVAX here guys
SNGX =MC $50M /Covid 19 Vaccine gem..The CHEAPEST of all Covid Vaccine stocks which is still under radar..Could be next INO or ALT
SNGX =MCap $50 Mil / 3 Cancer Drugs in Phase 3 with Data in Q4 / COVID 19 VACCINE programm with first data soon / Undiscovered
Soligenix (SNGX)
Market Cap $50 million
Price 1.90
Presentation
http://ir.soligenix.com/download/Soligenix+Corporate+Presentation+06.24.20FINAL.pdf
Soligenix Completes Enrollment in its Pivotal Phase 3 Clinical Trial of SGX942 for the Treatment of Oral Mucositis
https://finance.yahoo.com/news/soligenix-completes-enrollment-pivotal-phase-110000377.html
Final top-line results expected Q4 2020
SNGX: Q&A on COVID-19 Vaccine Candidate CiVax™…
https://finance.yahoo.com/news/sngx-q-covid-19-vaccine-093900828.html
As a reminder, following the positive topline data presented by the company for SGX-301 in CTCL, we continue to anticipate Phase 3 data for SGX-942 in oral mucositis in the fourth quarter of 2020. The company will also be joining the Russell Microcap Index effective June 29th, 2020, which should help to increase visibility within the investment community. Our current valuation is $12 per share.
SNGX =MC $50M /Covid 19 Vaccine gem..The CHEAPEST of all Covid Vaccine stocks which is still under radar..Could be next INO or ALT
SNGX =MCap $50 Mil / 3 Cancer Drugs in Phase 3 with Data in Q4 / COVID 19 VACCINE programm with first data soon / Undiscovered
Soligenix (SNGX)
Market Cap $50 million
Price 1.90
Presentation
http://ir.soligenix.com/download/Soligenix+Corporate+Presentation+06.24.20FINAL.pdf
Soligenix Completes Enrollment in its Pivotal Phase 3 Clinical Trial of SGX942 for the Treatment of Oral Mucositis
https://finance.yahoo.com/news/soligenix-completes-enrollment-pivotal-phase-110000377.html
Final top-line results expected Q4 2020
SNGX: Q&A on COVID-19 Vaccine Candidate CiVax™…
https://finance.yahoo.com/news/sngx-q-covid-19-vaccine-093900828.html
As a reminder, following the positive topline data presented by the company for SGX-301 in CTCL, we continue to anticipate Phase 3 data for SGX-942 in oral mucositis in the fourth quarter of 2020. The company will also be joining the Russell Microcap Index effective June 29th, 2020, which should help to increase visibility within the investment community. Our current valuation is $12 per share.
SNGX =MC $49 M/COVID 19 Vaccine + 3 Drugs in Phase 3 with data in Q4 this could be the next NVAX guys .MONSTER opportunity here
Soligenix (SNGX)
Market Cap $49 million
Price 1.83
Presentation
http://ir.soligenix.com/download/Soligenix+Corporate+Presentation+06.24.20FINAL.pdf
Soligenix Completes Enrollment in its Pivotal Phase 3 Clinical Trial of SGX942 for the Treatment of Oral Mucositis
https://finance.yahoo.com/news/soligenix-completes-enrollment-pivotal-phase-110000377.html
Final top-line results expected Q4 2020
SNGX: Q&A on COVID-19 Vaccine Candidate CiVax™…
https://finance.yahoo.com/news/sngx-q-covid-19-vaccine-093900828.html
As a reminder, following the positive topline data presented by the company for SGX-301 in CTCL, we continue to anticipate Phase 3 data for SGX-942 in oral mucositis in the fourth quarter of 2020. The company will also be joining the Russell Microcap Index effective June 29th, 2020, which should help to increase visibility within the investment community. Our current valuation is $12 per share.
SNGX =MC $49 M/COVID 19 Vaccine + 3 Drugs in Phase 3 with data in Q4 this could be the next NVAX guys .MONSTER opportunity here
Soligenix (SNGX)
Market Cap $49 million
Price 1.83
Presentation
http://ir.soligenix.com/download/Soligenix+Corporate+Presentation+06.24.20FINAL.pdf
Soligenix Completes Enrollment in its Pivotal Phase 3 Clinical Trial of SGX942 for the Treatment of Oral Mucositis
https://finance.yahoo.com/news/soligenix-completes-enrollment-pivotal-phase-110000377.html
Final top-line results expected Q4 2020
SNGX: Q&A on COVID-19 Vaccine Candidate CiVax™…
https://finance.yahoo.com/news/sngx-q-covid-19-vaccine-093900828.html
As a reminder, following the positive topline data presented by the company for SGX-301 in CTCL, we continue to anticipate Phase 3 data for SGX-942 in oral mucositis in the fourth quarter of 2020. The company will also be joining the Russell Microcap Index effective June 29th, 2020, which should help to increase visibility within the investment community. Our current valuation is $12 per share.
(KBSF) UP 30% in pre mkt ....Market cap $7 million --cash $21 million --book value $21 while stock still trading above $3 ..
TMBR = MC $26 M / Cash $25 M / MEGA Product Pipeline / Float 2 M / NEW Nasdaq stock = 1000% Upside potential and even then it would be still attractive .GL
https://assets.wallstreet-online.de/_media/8763/board/20200619162635-screenshot-2020-06-19-powerpoint-presentation-e02.png
KBSF =MC $5 M /Face Mask /Cash $20M /Book Value $21 per share while trading at $2.20 / Shares Out 2.6 M = MEGA opp here
KBSF =MC $5 M /Face Mask /Cash $20M /Book Value $21 per share / Shares Out 2.6 M = the MOST underpriced and undiscovred low float corona gem i ever have seen ..could be a 10 bagger in shorttime ....GLTA
KBSF =MC $6 M /Face Masks /Cash $20 M /Book Value $21 per share / Shares Out 2.6 M = the MOST underpriced and undiscovred low float corona gem i ever have seen
KBSF =MC $6 M /Face Masks /Cash $20 M /Book Value $21 per share / Shares Out 2.6 M = the MOST underpriced and undiscovred low float corona gem i ever have seen
TMBR =MAJOR breakout could start anytime now ...
Dirt cheap biotech gem
ETTX =MC $80 M / Cash $63 M / 2 MEGA Drugs with Phase 3 readouts in short term /Undiscovered low float stock
next $10 stock soon
EYEN =MCap $65 m / NDA submission for first drug likely next Quarter / 2 more BIG Drugs in Phase 3 with Data in short term ....Dirt cheap low float stock
MicroStat (Indication: Mydriasis) File NDA $300M+ Market Opportunity
MicroLine (indication:Presbyopia) Initiate and Complete Phase III VISION Study $2B+ Market Opportunity
MicroPine (Indication: Progressive Myopia) Complete Phase III CHAPERONE Enrollment $5B+ Market Opportunity
EYEN =MCap $65 m / NDA submission for first drug likely next Quarter / 2 more BIG Drugs in Phase 3 with Data in short term ....Dirt cheap low float stock
MicroStat (Indication: Mydriasis) File NDA $300M+ Market Opportunity
MicroLine (indication:Presbyopia) Initiate and Complete Phase III VISION Study $2B+ Market Opportunity
MicroPine (Indication: Progressive Myopia) Complete Phase III CHAPERONE Enrollment $5B+ Market Opportunity
STRONG BUY
(ETTX-DD) Low Valuation of $86 Million / STRONG Cash of $63 Million/ 2 attractive Drugs in late Phase 3 with LARGE market potential with first readout within 6-7 months / Insider & Institutional investors holding most of the shares /Low float stock = $15-20 stock here on this undiscovered biotech gem .GL
Presentation June
https://investors.entasistx.com/static-files/0bf75506-2d54-4b14-896a-6a3d5ed53472
Major Shareholders
Innoviva Inc...14M
Novo Holdings A/S...2.2M
AstraZeneca PLC...2.2M
Clarus Ventures, LLC...1.6M
Pivotal ...1.2M
Sofinnova ...1.2M
Frazier ...1.0M
TPG Capital, L.P...1.0M
Eventide Asset ...879.5K
Granahan ...154.7K
AYRO =MC $37 M/E-Cars/ EXPLODINGGGGGGGGGG
AYRO = MCap $38 M/ NEXT TESLA ? A MONSTER OPP
(AYRO) Market Cap $38 Million / Shares Out 12.5 M / has Cash untill late Q1 of next year / manufactures and already starts selling electric vehicles / COMPLETELY UNKNOWN COMPANY which went Pulic a few days ago = Undiscovered and MOST CHEAPEST EV maker out there could be a MEGA LIFETIME OPP like TSLA was at $20 in 2011 .STRONG BUY SUPER DUPA AGGRESSIVE and GL
Ayro Inc (AYRO)
Markt-Cap: $38 million
Price: $3
Shares Out: 12.5
Video Presentation and more infos (Watch It)
https://secure.ayro.com/merger/?main-site-popup
AYRO Along With Strategic Partner, Club Car, Expand Into Higher-Ed Market at Princeton and Penn State
https://www.businesswire.com/news/home/20200331005163/en/AYRO-Strategic-Partner-Club-Car-Expand-Higher-Ed
According to the Association for the Advancement of Sustainability in Higher Education (ASSHE), there are over 1,800 colleges and universities in the U.S. that have fleets of at least 400 vehicles. This represents a base of over 535,000 vehicles that are in need of converting over from gas-powered vehicles to electric vehicles. With an average conversion price of $14,000, this represents a potential market of more than $7 billion.
AYRO, Inc., a designer and manufacturer of purpose-built compact, light-duty emissions-free electric vehicles for urban, commercial, consumer and government markets, announces the Company’s first vehicle deliveries of its Club Car 411 to Canada and Mexico through its strategic partnership with Club Car, Inc. ("Club Car").
https://finance.yahoo.com/news/ayro-club-car-partnership-announce-130000175.html
AYRO, Inc. (AYRO), is a designer and manufacturer of purpose-built, automotive-grade electric vehicles (EV). The Company´s EV models include AYRO 311 and Club Car 411. AYRO 311 is a three-wheeled vehicle with inline seating and four-door access for professional and personal use. The Company offers its AYRO 311 with multiple configurations including fully enclosed two-seater, half doors and one-seater with the cargo area. The Club Car 411 is a compact all-electric vehicle suitable for low-speed logistics and cargo services. The Company offers Club Car 411 with multiple bed configurations including a fully enclosed box truck, pickup bed and flatbed. AYRO delivers electric vehicle solutions for campus management, last-mile delivery, urban commuting and closed campus transport.
AYRO =Mcap only $35 M /NEW on Nasdaq coulde be the next TESLA ..they already starts selling EV
Video Presentation and more infos here (WATCH IT)
https://secure.ayro.com/merger/?main-site-popup
Video Presentation and more infos here (WATCH IT)
https://secure.ayro.com/merger/?main-site-popup
WATCH THIS .BRUTAL OPPORTUNITY HERE
https://secure.ayro.com/merger/?main-site-popup
(AYRO) Market Cap $38 Million / Shares Out 12.5 M / has Cash untill late Q1 of next year / manufactures and already starts selling electric vehicles / COMPLETELY UNKNOWN COMPANY which went Pulic a few days ago = Undiscovered and MOST CHEAPEST EV maker out there could be a MEGA LIFETIME OPP like TSLA was at $20 in 2011 .STRONG BUY SUPER DUPA AGGRESSIVE and GL
Ayro Inc (AYRO)
Markt-Cap: $38 million
Price: $3
Shares Out: 12.5
Video Presentation and more infos (Watch It)
https://secure.ayro.com/merger/?main-site-popup
AYRO Along With Strategic Partner, Club Car, Expand Into Higher-Ed Market at Princeton and Penn State
https://www.businesswire.com/news/home/20200331005163/en/AYRO-Strategic-Partner-Club-Car-Expand-Higher-Ed
According to the Association for the Advancement of Sustainability in Higher Education (ASSHE), there are over 1,800 colleges and universities in the U.S. that have fleets of at least 400 vehicles. This represents a base of over 535,000 vehicles that are in need of converting over from gas-powered vehicles to electric vehicles. With an average conversion price of $14,000, this represents a potential market of more than $7 billion.
AYRO, Inc., a designer and manufacturer of purpose-built compact, light-duty emissions-free electric vehicles for urban, commercial, consumer and government markets, announces the Company’s first vehicle deliveries of its Club Car 411 to Canada and Mexico through its strategic partnership with Club Car, Inc. ("Club Car").
https://finance.yahoo.com/news/ayro-club-car-partnership-announce-130000175.html
AYRO, Inc. (AYRO), is a designer and manufacturer of purpose-built, automotive-grade electric vehicles (EV). The Company´s EV models include AYRO 311 and Club Car 411. AYRO 311 is a three-wheeled vehicle with inline seating and four-door access for professional and personal use. The Company offers its AYRO 311 with multiple configurations including fully enclosed two-seater, half doors and one-seater with the cargo area. The Club Car 411 is a compact all-electric vehicle suitable for low-speed logistics and cargo services. The Company offers Club Car 411 with multiple bed configurations including a fully enclosed box truck, pickup bed and flatbed. AYRO delivers electric vehicle solutions for campus management, last-mile delivery, urban commuting and closed campus transport.
Ayro is NOT old DCAR they mergered with DCAR its a different company buddy